Manufacturing Chemist Stand Side with Syntegon

Published: 24-Jun-2024
Cell & Gene Therapy Contamination Control

Christian Lavarreda, Global Product Manager at Syntegon, speaks to Manufacturing Chemist

At ACHEMA 2024 in Frankfurt, Manufacturing Chemist spoke with Syntegon's Global Product Manager, Christian Lavarreda, to find out more about its novel modular bioprocessing platform, which can facilitate the simple and convenient routine maintenance and cleaning of a pharmaceutical cleanroom. 

Syntegon has also 'decluttered' the cleanroom space with its novel technology, as well as improving the ergonomics of the system.

Christian also explains the range of biopharmaceutical processes that can be facilitated by such a platform.

 

Manufacturing Chemist Stand Side...

"Manufacturing Chemist Stand Side" is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of "Manufacturing Chemist Stand Side" contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

 

 

  • Companies:
  • Syntegon Technology
See more

You may also like

Regulatory

PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency

Read more
The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)

Trending Articles

  1. PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)
  2. Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways
  3. Ascend Advanced Therapies expands US footprint through Advanced BioScience Laboratories merger Ascend's collaboration with EW Healthcare partners will expand its reach in the US pharmaceutical market through capital investment and an uptick in GMP AAV manufacturing capacity
  4. Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies
  5. Autolus Therapeutics' CAR-T therapy, Aucatzyl, bags FDA approval for ALL Aucatzyl (obecabtagene autoleucel) is the first CAR-T therapy to receive FDA approval with no risk evaluation mitigation strategy requirement

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Regulatory

PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency

The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)
Finance

Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines

The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways
Manufacturing

Ascend Advanced Therapies expands US footprint through Advanced BioScience Laboratories merger

Ascend's collaboration with EW Healthcare partners will expand its reach in the US pharmaceutical market through capital investment and an uptick in GMP AAV manufacturing capacity
Ingredients

Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing

The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies
Regulatory

Autolus Therapeutics' CAR-T therapy, Aucatzyl, bags FDA approval for ALL

Aucatzyl (obecabtagene autoleucel) is the first CAR-T therapy to receive FDA approval with no risk evaluation mitigation strategy requirement
Manufacturing

Ensuring sterility and precision in pharma

Specialty bearings for efficiency in pharmaceutical production
Manufacturing

Neogap Therapeutics and NorthX Biologics team up to scale novel cancer cell therapy

CDMO NorthX Biologics will work with Neogap to determine advanced manufacturing protocols for Neogap's personalised cancer cell therapy
Subscribe now